Ideaya Biosciences Inc (NASDAQ:IDYA) has a beta value of 0.27 and has seen 1.36 million shares traded in the last trading session. The company, currently valued at $1.59B, closed the last trade at $18.18 per share which meant it gained $1.1 on the day or 6.44% during that session. The IDYA stock price is -144.33% off its 52-week high price of $44.42 and 26.02% above the 52-week low of $13.45. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.85 million shares traded. The 3-month trading volume is 1.16 million shares.
The consensus among analysts is that Ideaya Biosciences Inc (IDYA) is Buy stock at the moment, with a recommendation rating of 1.15. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 11 have rated it as a Hold, with 10 advising it as a Buy. 0 have rated the stock as Underweight.
Ideaya Biosciences Inc (NASDAQ:IDYA) trade information
Sporting 6.44% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the IDYA stock price touched $18.18 or saw a rise of 2.36%. Year-to-date, Ideaya Biosciences Inc shares have moved -29.26%, while the 5-day performance has seen it change 8.54%. Over the past 30 days, the shares of Ideaya Biosciences Inc (NASDAQ:IDYA) have changed -1.41%. Short interest in the company has seen 9.95 million shares shorted with days to cover at 10.41.
Wall Street analysts have a consensus price target for the stock at $38.5, which means that the shares’ value could jump 52.78% from current levels. The projected low price target is $27.0 while the price target rests at a high of $50.0. In that case, then, we find that the current price level is -175.03% off the targeted high while a plunge would see the stock gain -48.51% from current levels.
Ideaya Biosciences Inc (IDYA) estimates and forecasts
The company’s shares have lost -41.35% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -0.01% over the past 5 years. Earnings growth for 2025 is a modest 16.94% while over the next 5 years, the company’s earnings are expected to increase by 15.86%.
IDYA Dividends
Ideaya Biosciences Inc is expected to release its next earnings report on 2025-Feb-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Ideaya Biosciences Inc (NASDAQ:IDYA)’s Major holders
Insiders own 1.04% of the company shares, while shares held by institutions stand at 109.58% with a share float percentage of 110.73%. Investors are also buoyed by the number of investors in a company, with Ideaya Biosciences Inc having a total of 290.0 institutions that hold shares in the company. The top two institutional holders are FMR LLC with over 11.27 million shares worth more than $395.69 million. As of 2024-06-30, FMR LLC held 14.4557% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 6.81 million shares as of 2024-06-30. The firm’s total holdings are worth over $239.02 million and represent 8.7321% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . As of Feb 28, 2025 , the former fund manager holds about 4.68% shares in the company for having 4.1 shares of worth $74.53 million while later fund manager owns 2.71 shares of worth $49.19 million as of Dec 31, 2024 , which makes it owner of about 3.09% of company’s outstanding stock.
